Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab

Ann Allergy Asthma Immunol. 2012 Feb;108(2):123-4. doi: 10.1016/j.anai.2011.11.004. Epub 2011 Dec 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Aged
  • Aged, 80 and over
  • Anaphylaxis / diagnosis
  • Anaphylaxis / drug therapy
  • Anaphylaxis / etiology
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Autoimmune Diseases / drug therapy*
  • Drug Hypersensitivity / diagnosis
  • Drug Hypersensitivity / drug therapy
  • Drug Hypersensitivity / etiology*
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin E / immunology
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Italy
  • Male
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Treatment Failure
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Urticaria / diagnosis
  • Urticaria / drug therapy
  • Urticaria / etiology
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Immunoglobulin E
  • Infliximab
  • Adalimumab
  • Etanercept